Blue module pathway enrichment analysis using Innate DB (top 15 enriched pathways)
| Pathway name | FDR | Gene symbols |
| IL-4 signalling | 0.01 | JAK1; PTPN6 |
| LIF signalling TSLP | <0.0001 | CREBBP; JAK1 DBNL; DOCK5; JAK1; KDM3B; LYN; PTPN6; STK10; WIPF1; ZZEF1 |
| BCR | <0.0001 | ATP2B4; CHST15; DBNL; LCP2; LYN; PTPN6; RAPGEF1; RPS6KA1; SH3BP2 |
| TCR | <0.0001 | CREBBP; DBNL; DIAPH1; ELMO1; LCP2; LYN; PTPN6; RAPGEF1; SH2D3C; SH3BP2; WIPF1 |
| IL-5 | <0.001 | JAK1; LYN; PTPN6; RAPGEF1; RPS6KA1 |
| IL-4 | 0.01 | CREBBP; JAK1; PTPN6; SPI1 |
| EGFR1 | 0.01 | ACTN4; EPS15L1; IQGAP1; JAK1; LYN; PTPN6; PTPRE; RPS6KA1; SH2D3C |
| IL-3 | 0.01 | JAK1; LYN; PTPN6; RAPGEF1 |
| RANKL | 0.01 | JAK1; LYN; PTPN6; SPI1 |
| Kit receptor | 0.016 | LYN; PTPN6; RPS6KA1; WIPF1 |
| Prolactin | 0.016 | CREBBP; JAK1; LYN; PTPN6 |
| IL-2 | 0.029 | JAK1; LYN; PTPN6 |
| IL-6 | 0.03 | CREBBP; JAK1; LYN |
| IL-11 | 0.04 | JAK1; RPS6KA1 |
BCR, B-cell receptor; EGFR, epidermal growth factor receptor; FDR, false discovery rate; IL, interleukin; LIF, leukaemia inhibitory factor; RANKL, receptor activator of nuclear factor kappa-Β ligand; TCR, T-cell receptor; TSLP, thymic stromal lymphopoietin.